Artikelname:
(8S-cis)-10-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione hydrochloride
Gruppe:
Biochemicals
CAS-Nummer:
25316-40-9
EC-Nummer:
246-818-3
Synonyme:
fi6804, Doxorubicin (Adriamycin), Doxorubicin Hydrochloride, Lipodox, Doxorubicin (hydrochloride), DOX,Hydroxydaunorubicin hydrochloride, FI 106, Adriamycin, hydrochloride, CAELYX, Hydroxydaunorubicin hydrochloride, Dox hydrochloride, ADRIACIN, Doxorubicin (Adriamycin) HCl, Ardriamycin, Caely, 14-hydroxydaunomycin hydrochloride, adriamycin hydrochloride, Doxorubicin HCl, DOX, ADR, DOX HCl
IUPAC-Name:
(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
Molekularformel:
C27H30ClNO11
Molekulargewicht:
579.98 g/mol
Siedepunkt:
810.3ºC at 760 mmHg
Flammpunkt:
443.8ºC
Schmelzpunkt:
216ºC
HS-Code:
2941909000
Bedenkenanzeige:
R45; R22
Gefahrenhinweis:
H302; H315; H319; H350
Warnerklärung:
P201; P305 + P351 + P338; P308 + P313
Signale:
Danger